TABLE 2.

Inclusion and exclusion criteria for study participants

Inclusion criteria	Exclusion criteria
Male or female, aged ≥12 years at screening	Acute upper or lower respiratory tract infection ≤4 weeks prior to randomisation
Diagnosis of CF (positive sweat chloride ≥60 mEq·L−1, or genotype with two identifiable mutations and ≥1 clinical phenotypic feature of CF)	Pulmonary exacerbation requiring the use of antibiotics or oral corticosteroids ≤4 weeks prior to randomisation
FEV1 (according to Global Lung Initiative) ≥40 and ≤90% pred at screening and pre-dose at visit 2

CF: cystic fibrosis; FEV₁: forced expiratory volume in 1 s.